The Overlooked Valve: Why Women With Aortic Stenosis Fall Through the Cracks
Pam R. Taub, MD, FACC, FASPC
Clinical Perspective on New Therapies in Resistant Hypertension
Clyde W. Yancy, MD
Highlights of the Latest Hypertension Guidelines
Targeting Vascular KCNQ5 Channels: A Promising Strategy for Blood Pressure Control
Rethinking Hormones: Testosterone and Estrogen in Women’s Heart Health
Susan Davis
Navigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control
Jun-ichi Abe
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
Scott Solomon, MD
The Fifth Pillar? Closing the Gap in HFrEF
Carolyn S. P. Lam, MBBS, PhD
Javed Butler, MD
Stephen J. Greene, MD, FACC, FHFSA
Exploring Patient Perspectives on Genetic Testing for ATTR-CM
Shelina Ramnarine, PhD
Quan Bui, MD
Precision Medicine in Obstructive HCM Care: The Promise of Cardiac Myosin Inhibitors
Ahmad Masri, MD, MS
DARE AF Trial: Dapagliflozin to Reduce AF Burden After Catheter Ablation in Patients Without Diabetes or Heart Failure
DECAF Trial: Does Eliminating Coffee Reduce Atrial Fibrillation Recurrence in Symptomatic Patients?
Christopher Wong
OCEAN Trial at AHA 2025: Anticoagulation After AF Ablation in High-Risk Patients
Atul Verma, MD
POLY HF Trial: A Polypill Strategy for Heart Failure With Reduced Ejection Fraction (HFrEF)
Ambarish Pandey, MD
The Lp(a)-Lowering Landscape: Navigating Current and Future Therapeutic Options
Erin Michos
The LDL-C-Lowering Landscape: Navigating Current and Future Therapeutic Options
Prof. Kausik Ray
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.